Alvogen

New CEO for Kunwha Pharmaceuticals in South-Korea

Mon, 01 Apr 2013 00:00:00 GMT

Alvogen is pleased to announce the appointment of Joo-Hyung Lee as CEO of Kunwha Pharmaceuticals in South-Korea.

Dr Saral Thangam profiled among the most influential women in bioscience industry

Thu, 28 Mar 2013 08:26:56 GMT

Dr Saral Thangam, Managing Director of Alvogen‘s subsidiary, Norwich Clinical Services in Bangalore, India, has been featured in a recent issue of Biospectrum Magazine.

Elin Gabriel named STEP honoree

Mon, 18 Feb 2013 13:51:00 GMT

Alvogen’s Chief Operating Officer, Elin Gabriel, has been named one of the first STEP (Science, Technology, Engineering and Production) honorees. She accepted her award at a ceremony in Washington DC, on February 5.

Alvogen’s senior management team gathers in Iceland for annual Kick-off meeting

Tue, 12 Feb 2013 09:06:34 GMT

Eighty people from Alvogen’s senior management team met in Reykjavik, Iceland, in late January to discuss business plans and the company’s vision for the year.

Alvogen acquires Labormed Pharmaceuticals

Tue, 15 Jan 2013 09:29:44 GMT

Alvogen, the international pharmaceuticals company, today announces that it has acquired Labormed Pharmaceuticals (“Labormed”) as of December 2012

Alvogen supports UNICEF during Red Nose Day

Wed, 09 Jan 2013 10:09:00 GMT

In December, Alvogen supported children's charity UNICEF by participating in the Red Nose Day campaign and signing an agreement to continue the party‘s cooperation.

Alvogen makes waves at CPhI 2012

Tue, 30 Oct 2012 20:52:10 GMT

In October, Alvogen participated in the world’s largest pharmaceutical fair, CPhI, for this first time.

Alvogen to Present at Jeffries 2012 Global Healthcare Conference

Tue, 23 Oct 2012 09:36:33 GMT

Kevin Bain, Chief Financial Officer of Alvogen, will present at the Jeffries 2012 Global Healthcare Conference in London on 15th of November.

Alvogen acquires majority of shares in Kunwha Pharmaceuticals

Thu, 18 Oct 2012 19:50:04 GMT

Alvogen announced today that it has entered into an agreement to acquire a majority share in Kunwha Pharmaceuticals (“Kunwha”) through a combination of new shares issued by Kunwha to Alvogen and the acquisition of shares owned by Mr. Hongsun Chang, Kunwha´s Chairman and related parties.

Alvogen Macedonia raises awareness about osteoporosis

Tue, 04 Sep 2012 12:03:01 GMT

In June, a group of employees from Alvogen’s Macedonia office teamed up to raise awareness about osteoporosis, a potentially fatal disease characterized by a reduction in bone mineral density, when the bones become less rigid and are vulnerable to breaking.